DLGAP2 AS A THERAPEUTIC TARGET FOR AND ALZHEIMER'S DISEASE AND AGE-RELATED COGNITIVE… Application WO-2020092862-A1 World Intellectual Property Organisation (WIPO) 07 May 2020